Are you a technical investor? If so, it may be time to consider Ascendis Pharma A/S (ASND - Free Report) for your portfolio. The company just saw its 50 Day Moving Average breakout above its 200 Day Simple moving average, a trend that could indicate some bullishness in the future for ASND.
This trend may have already begun, as shares of ASND have moved by higher by 12.2% in just the past month. Plus, ASND has earned itself a Zacks Rank #2 (Buy), so there is plenty of reason to believe that the run for Boot Barn has plenty of life left.
More bullishness may especially be the case when investors consider what has been happening for ASND on the earnings estimate revision front lately. No estimate has gone lower in the past two months, compared to 2 higher, while the consensus estimate has also moved higher too.
So given this move in estimates, and the positive technical factors, investors may want to watch this breakout candidate closely for more gains in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>